Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – LiveWire Ergogenics Inc. (OTC: LVVV), a forward-thinking company specializing in identifying and monetizing current and future...
-
NEW YORK, Oct. 16, 2019 (GLOBE NEWSWIRE) -- LiveWire Ergogenics Inc. (OTC: LVVV), a forward-thinking company specializing in identifying and monetizing current and future trends in the health and...
-
ANAHEIM, CA--(Marketwired - February 02, 2017) - LiveWire Ergogenics, Inc. (OTC PINK: LVVV), the leader in performance based functional chew development and marketing, announced today modification of...
-
ANAHEIM, CA--(Marketwired - January 18, 2017) - LiveWire Ergogenics, Inc. (OTC PINK: LVVV) a performance nutrition product development and marketing company, announced today an addition to its...
-
ANAHEIM, CA--(Marketwired - November 03, 2016) - LiveWire Ergogenics, Inc. (OTC PINK: LVVV) a performance nutrition product development and marketing company, announced today that it has signed a...
-
YORBA LINDA, CA--(Marketwired - Sep 23, 2015) - LiveWire Ergogenics, Inc (OTC PINK: LVVV), a performance nutrition company, announced today that the company is accepting applications from...
-
YORBA LINDA, CA--(Marketwired - Sep 17, 2015) - LiveWire Ergogenics, Inc. (OTC PINK: LVVV) announced today the company has launched its national advertising campaign to be shown on over nearly 200...
-
YORBA LINDA, CA--(Marketwired - Feb 25, 2015) - LiveWire Ergogenics, Inc (OTC PINK: LVVV), a performance nutrition company, announced today the release of Granultra™ the Company's newest...
-
YORBA LINDA, CA--(Marketwired - Dec 4, 2014) - LiveWire Ergogenics, Inc. (OTCQB: LVVV) today announced it will be attending the 2014 McKenzie's Rage at the River SNORE (Southern Nevada Off Road...
-
YORBA LINDA, CA--(Marketwired - Aug 26, 2014) - LiveWire Ergogenics Inc. (OTCQB: LVVV), through its international partner, Lu'an Kaixuan Hemp Company Ltd., has obtained Chinese government approval...